STOCK TITAN

MARIMED INC - MRMD STOCK NEWS

Welcome to our dedicated page for MARIMED news (Ticker: MRMD), a resource for investors and traders seeking the latest updates and insights on MARIMED stock.

MariMed Inc. is a multi-state cannabis operator dedicated to enhancing lives daily through high-quality products, values, and actions. The company develops, owns, and manages state-licensed cannabis facilities, excelling in horticultural principles, cannabis cultivation, infused products, and dispensary operations. With expert management, MariMed has seen consistent growth and success through proprietary formulations reflected in award-winning brands like Betty's Eddies, Nature’s Heritage, InHouse, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations.

Rhea-AI Summary

MariMed, Inc. (MRMD) reported impressive financial results for Q3 2021, with revenue of $33.2 million, a 147% increase year-over-year. The adjusted EBITDA reached $12.9 million, marking a 213% increase compared to the same quarter last year. Net income rose to $2.1 million, up 25% year-over-year. The company also maintained working capital of $27.3 million. MariMed’s retail operations in Illinois and Massachusetts saw revenue growth of 207% year-over-year, demonstrating strong performance despite an industry-wide slowdown. Full-year guidance remains at $118 million in revenue and $42 million in adjusted EBITDA.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.11%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

MariMed, Inc. (OTCQX: MRMD), a multi-state cannabis operator, announced it will release its third quarter 2021 financial results on November 15, 2021, after market close. Management will hold a conference call on November 16, 2021, at 8:00 a.m. EDT to discuss these results. The call will be accessible via the company's Investor Relations website, with a playback available for 30 days. MariMed is focused on providing high-quality cannabis products and has developed a robust portfolio, including brands like Betty's Eddies® and Nature’s Heritage™.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
Rhea-AI Summary

MariMed, Inc. (OTCQX: MRMD) announced the appointment of Steve West as Vice President of Investor Relations. With nearly 20 years of experience, West has held significant roles at renowned companies like Neptune Wellness Solutions and Acreage Holdings. He is recognized for his expertise in investor relations, previously serving as a successful sell-side analyst. His military background includes over 14 years in the U.S. Navy. This strategic appointment aims to enhance MariMed's communication with capital markets and strengthen investor relations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.14%
Tags
management
-
Rhea-AI Summary

MariMed, Inc. (OTCQX: MRMD) announced health and safety protocols for its annual meeting on September 23, 2021, at Hilton Boston/Dedham. Only stockholders will be admitted, with record stockholders confirmed from company records. Attendees must present proof of vaccination or a negative COVID-19 test within 72 hours. Masks are mandatory, and no food or beverages are allowed. The company focuses on health and wellness in the cannabis sector, managing state-licensed facilities and producing award-winning products such as Betty's Eddies® and Nature’s Heritage™.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.18%
Tags
covid-19
-
Rhea-AI Summary

MariMed, Inc. (OTCQX: MRMD) has launched new SKUs of its popular Betty’s Eddies cannabis-infused fruit chews, introducing single-serving options and multi-packs after customer requests. The single-serving packs aim to enhance trial among new consumers and facilitate impulse purchases. Multi-packs will feature an assortment of classic flavors, allowing users to explore different options. Betty’s Eddies chews are made with full-spectrum cannabis oil and organic ingredients, and are already the leading cannabis edible in Maryland and Massachusetts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.21%
Tags
none
Rhea-AI Summary

MariMed, Inc. (OTCQX: MRMD), a multi-state cannabis operator, announced its participation in several upcoming conferences. CEO Bob Fireman will present at the Cannabis Virtual Investor Conference on September 8th and the Echelon Capital Markets U.S. MSO Cannabis Conference on September 22nd. Additionally, management will hold one-on-one meetings at the Beacon Securities Virtual Cannabis Conference on September 9th. Fireman will also participate in a panel discussion at the Burns Levinson Conference on September 28th. MariMed is dedicated to high-quality cannabis products and has shown consistent growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.67%
Tags
none
-
Rhea-AI Summary

MariMed Inc. (MRMD:OTCQX) has announced key appointments to enhance its brand and marketing strategies. Robert Hall, former CMO of Sam Adams, joins as Senior Brand and Marketing Advisor, focusing on brand strategy and team expansion. Kevin Compagna takes on the role of VP, Wholesale & Licensing, tasked with increasing revenues and market share for top products like Betty’s Eddies and Nature’s Heritage. The company's management emphasizes a strategic plan aimed at maximizing revenue potential while maintaining operational efficiency.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.06%
Tags
none
-
Rhea-AI Summary

MariMed, a multi-state cannabis operator, announced a collaboration with Emack & Bolio’s to launch a line of cannabis-infused vegan and dairy ice creams. Utilizing MariMed’s formulations rich in cannabinoids and terpenes, the products are set to debut in Massachusetts before expanding to other legal markets. This partnership aims to leverage the growing trend in the ice cream market towards healthier options, as noted by Mordor Intelligence, which projects a 3% growth driven by demand for natural ingredients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.18%
Tags
none
Rhea-AI Summary

MariMed Inc. (MRMD:OTCQX) announced that CEO Bob Fireman will speak at the Benzinga Virtual Cannabis Capital Conference on October 15th. The conversation will address the company’s revenue growth in the Massachusetts and Illinois cannabis markets and its consolidation strategy. Additionally, MariMed management will hold one-on-one meetings with institutional investors to discuss its growth strategy amid evolving regulations. Interested investors can register for the event online.

MariMed develops state-licensed cannabis facilities and industry-leading products, focused on health and wellness.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.9%
Tags
conferences

FAQ

What is the current stock price of MARIMED (MRMD)?

The current stock price of MARIMED (MRMD) is $0.11814 as of December 20, 2024.

What is the market cap of MARIMED (MRMD)?

The market cap of MARIMED (MRMD) is approximately 55.3M.

What is MariMed Inc. known for?

MariMed Inc. is recognized for its high-quality cannabis products, state-licensed facilities, and award-winning brands like Betty's Eddies and Nature’s Heritage.

What are MariMed Inc.'s core operations?

MariMed Inc. develops, owns, and manages cannabis facilities, excelling in horticultural principles, cultivation, infused products, and dispensary operations.

Who leads MariMed Inc.'s management team?

MariMed Inc. is led by an experienced management team that has driven consistent growth and success for the company and its business units.

What products does MariMed Inc. offer?

MariMed Inc. offers a range of products under various brands, including Betty's Eddies, Nature’s Heritage, InHouse, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations.

How can one access MariMed Inc.'s products?

MariMed Inc.'s cannabis products are distributed to nearly every dispensary in the state of Maryland.

What recent acquisitions has MariMed Inc. made?

MariMed Inc. recently acquired an adult-use Thrive Wellness dispensary in Upper Marlboro, Maryland, further expanding its presence in the high-growth adult-use market.

What significant development has MariMed Inc. celebrated in the cannabis industry?

MariMed Inc. is enthusiastic about the impending reclassification of cannabis from Schedule I to Schedule III under the Controlled Substances Act, which will have substantial positive implications for the industry.

What financial strength does MariMed Inc. demonstrate?

MariMed Inc. has shown financial resilience, reporting consistent growth, positive adjusted EBITDA, and anticipation of millions of dollars in tax savings after the elimination of Section 280E.

How does MariMed Inc. view the future of the cannabis industry?

MariMed Inc. expresses optimism for major positive changes in the industry, including increased access to capital, mainstream acceptance, and better financial services.

Where can one get more information about MariMed Inc.?

For additional information about MariMed Inc., visit their official website at www.marimedinc.com.

MARIMED INC

OTC:MRMD

MRMD Rankings

MRMD Stock Data

55.29M
280.32M
14.03%
0.3%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Norwood